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Abstract
Purpose Little is known about the apoptotic mechanisms
involved in abnormal spermatogenesis. In order to describe
the significance of apoptosis in azoospermia, testicular tis-
sue from abnormal spermatogenesis was analysed.
Methods Testicular treatment biopsies were obtained from 27
men. Five presented oligozoospermia, 9 obstructive
azoospermia (4 congenital bilateral absence of the vas
deferens; 5 secondary azoospermia) and 13 non-
obstructive azoospermia (5 hypospermatogenis; 3 matura-
tion arrest; 5 Sertoli-cell-only syndrome). Immunohisto-
chemical staining was performed for active caspases-3, −8
and −9. The presence of active caspases in Sertoli cells and
germ cells was analyzed using stereological tools.
Results Increased active caspase-3 was found in Sertoli-cell-
only syndrome. No significant differences were found in mat-
uration arrest. In hypospermatogenesis, primary spermatocytes
were the germ cells with higher active caspases. Oligozoosper-
mia and secondary obstruction showed significant differences
among germ cells for the presence of all active caspases. In
oligozoospermia, spermatogonia presented significant in-
creased active caspase-9 in relation to active caspase-8. In
primary obstruction and hypospermatogenesis, germ cells pre-
sented significant increased active caspases-3 and −9.
Conclusions Results suggest that increased active caspase-3
might be involved in Sertoli-cell-only syndrome etiology. In
cases of hypospermatogenesis, intrinsic lesions at the meiotic
stage seem to be related to the pathology. In secondary ob-
struction apoptosis is suggested to be initiated due to extrinsic
and intrinsic lesions, whereas in primary obstruction only the
intrinsic apoptotic pathway seems to be present. Finally, in
oligozoospermic patients spermatogonia death by mitochon-
drial damage additionally to meiosis malfunctioning, might be
on the origin of the decreased sperm output.
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Introduction
During normal development of an organism a balance be-
tween cell proliferation and cell apoptosis is observed.
Capsule Apoptotic mechanisms in testicular tissue from men with
abnormal spermatogenesis are described. Immunohistochemical
staining performed for active caspases-3, -8 and -9, showed the
involvement of apoptosis in oligozoospermia, obstructive azoospermia
and non-obtructed azoospermia, except for maturation arrest.
C. Almeida (*) :A. Barros
Department of Genetics, Faculty of Medicine,
University of Porto, Porto 4200-319, Portugal
e-mail: carola@med.up.pt
S. Correia
Department of Hygiene and Epidemiology, Faculty of Medicine,
University of Porto, Porto 4200-319, Portugal
S. Correia
Institute of Public Health, University of Porto, Porto 4050-600,
Portugal
E. Rocha
Department of Microscopy, Laboratory of Histology,
Institute of Biomedical Sciences Abel Salazar (ICBAS), UMIB,
University of Porto, Porto 4050-313, Portugal
Â. Alves :M. Sousa
Department of Microscopy, Laboratory of Cell Biology, ICBAS,
UMIB, University of Porto, Porto 4050-313, Portugal
L. Ferraz
Department of Urology, Hospital Centre of Vila Nova de Gaia,
Vila Nova de Gaia 4434-502, Portugal
J. Silva :M. Sousa :A. Barros
Centre for Reproductive Genetics Alberto Barros, Porto 4100-009,
Portugal
J Assist Reprod Genet (2013) 30:487–495
DOI 10.1007/s10815-013-9938-8
However, under certain stimuli, this balance is disrupted and
cell proliferation or cell death by apoptosis deregulation
occur, being on the origin of several proliferative and de-
generative diseases [11, 30].
Caspases are a family of proteins essential in the apo-
ptotic mechanism. Upon an apoptotic stimulus, initiator
caspases are activated starting the biochemical apoptotic
cascade. The initiator caspases-8 and −9 are responsible
for the extrinsic and intrinsic apoptotic pathway activation,
respectively, leading to the most important effector cas-
pase activation: caspase-3. Caspase-3 activation marks
the point of no return in the apoptotic process and is
responsible for key proteins cleavage leading to final
cell disassembly [5].
During spermatogenesis, there is a requirement of
germ cell death by apoptosis in order to maintain normal
germ cell development and to achieve a normal sperm
output [10]. During this process, damaged and/or exces-
sive germ cells are phagocytised by Sertoli cells through
a Fas/FasL apoptotic system dependent-manner [25]. Ap-
optotic markers like active caspase-3 [1, 20, 32], phos-
phatidylserine (PS) externalization [3, 31] and DNA
fragmentation [6, 9, 20, 21] were described to be present
in ejaculated sperm from men with normal semen param-
eters. However, increased rates of ejaculated sperm apo-
ptosis were described in conditions of abnormal sperm
output, mainly related to abnormalities of sperm concen-
tration, morphology or rapid progressive motility values
[1, 3, 6, 9, 20, 21, 24, 31–34].
In cases of disrupted spermatogenesis with no ejacu-
lated sperm (azoospermia), testicular sperm apoptosis
has also been a subject of discussion in the literature.
Increased rates of testicular sperm with active caspase-3
and PS externalization were found in cases of azoosper-
mia, either in obstructive azoospermia (congenital ab-
sence of the vas deferens and secondary obstructive
azoospermia) or in hypospermatogenesis when compared
to ejaculated sperm [2, 3], suggesting a relationship
between testicular sperm apoptosis and testicular failure.
Additionally, increased rates of spermatids with PS ex-
ternalization were described in men with incomplete
spermiogenesis failure [29]. Nuclear and mitochondrial
damage in cases of secondary obstructive azoospermia and
hypospermatogenesis, respectively, were suggested to be on
the origin of testicular sperm apoptosis [2]. However, rates of
germ cell apoptosis and possible activation mechanisms in-
volved in obstructive and non-obstructive azoospermia are
still poorly understood.
Results reported so far show discordant and inconclusive
results for the role of apoptosis during testicular failure.
The aims of the present study were to determine, using a
stereological approach, the rates of Sertoli cell and germ cells
(spermatogonia, primary and secondary spermatocytes and
round spermatids) with active caspase-3 (effector), active
caspase-8 (initiator; extrinsic pathway) and active caspase-9
(initiator; intrinsic pathway), in cases with oligozoospermia
and in cases with obstructive and non-obstructive azoosper-
mia. To search for a possible apoptotic activation mechanism,
comparisons between the rates of Sertoli cells and germ cell
stages with active caspases-8 and −9 were performed, both per
syndrome and between syndromes.
Methods
Patients
According to the National Law on Medically Assisted
Procreation (PMA, Law 32/2006) and the National
Council on Medically Assisted Procreation guidelines,
testicular tissues were used after patient informed and written
consent.
Testicular tissue was obtained from 27 men undergoing a
treatment testicular biopsy during assisted reproduction
techniques. Cell characterization for diagnosis was per-
formed during the testicular biopsy procedure in an inverted
Nikon microscope equipped with Hoffman optics on a heated
stage (33 °C).
Five patients had oligozoospermia but normal testicular
histology. The other 22 patients were diagnosed as azoo-
spermic and subdivided into different groups. Obstructive
azoospermia was diagnosed in 9 patients based on con-
genital bilateral absence of the vas deferens (CBAVD, n=
4) and secondary obstruction (n=5). At the moment of
testicular biopsy, all presented numerous germ cells (all
stages) and numerous testicular spermatozoa with in situ
and slow progressive motility. Azoospermia with a non-
obstructive origin was found in 13 patients based on the
presence of [1] reduced number of germ cells and sper-
matozoa (hypospermatogenesis, n=5), [2] spermatogenic
arrest at the secondary spermatocyte stage (maturation
arrest, n=3) and [3] seminiferous tubules with only Sertoli
cells (Sertoli-cell-only syndrome, SCOS, n=5) (defined
according to [22]). Testicular volumes varied according
to pathology: 12–22 ml (oligozoospermia, hypospermato-
genesis, SCOS), 22 ml (CBAVD), 15–22 ml (secondary
obstruction) and 18–20 ml (maturation arrest). All patients
presented normal karyotypes and absence of Y chromo-
some microdeletions.
Testicular tissue sampling and preparation for histological
analysis
Testicular tissue was obtained during treatment testicular
biopsy as previously described [27]. Testicular sample
biopsies volume was measured by water displacement
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and all presented volumes approximately of 0.016 ml.
Samples were fixed in 4 % Paraformaldheide (Merck,
Darmstadt, Germany) in PBS (Phosphate Buffered Saline,
Sigma, St. Louis, USA). After fixation, samples were
washed in PBS, dehydrated in ethanol series, and then
embedded in paraffin (Merck).
Histological analysis
With a manual Minot microtome (American Optical, USA), 10
3μm sectionsweremade in each paraffin block and transferred
to Vectabound Reagent treated slides (Vector Laboratories,
Burlingame, USA). Haematoxylin-eosin (Hemalumen Mayer,
Merck; Surgipath Medical Industries, Peterborourg) staining
was performed in all samples to confirm testicular diagnosis
and tissue integrity.
Immunohistochemistry
Immunostaining for caspase-3 and −9 was performed using
Vectastain ABC Kit (Vector Laboratories) according to manu-
facturer’s instructions. Briefly, paraffin sections were deparaf-
finised in xylol and rehydratated in ethanol series. To suppress
endogenous peroxidase activity, tissue sections were treated
with 3 % hydrogen peroxide (Hydrogen Peroxide 30 %,
Merck) in distilled water. After 1 h of incubation with 5 % of
normal horse serum (RT, Vectastain ABC Kit; diluted in 0.1 %
Tween20/PBS), primary antibody was incubated overnight at
4 °C: active caspase-3 (Monoclonal Anti-Human/Mouse
Cleaved Caspase-3 Antibody, R&D Systems, Minneapolis,
USA; 1:150 diluted in 5 % normal horse serum); active
caspase-9 (Monoclonal Anti-Caspase-9 Cleavage Site Specif-
ic, Sigma; 1:50 diluted in 5 % normal horse serum). Biotiny-
lated secondary antibody (Vectastain ABC Kit, 30 min, RT)
and ABC reagent (Vectastain ABC Kit, 30 min, RT) were
incubated according to manufacturer instructions. The final
colorimetric reaction was performed using DAB (3,3′-Dia-
minobenzidine; Sigma; final concentration: 0.05 % in
0.015 % H2O2), nuclei counterstained with haematoxylin
(Vector Laboratories) and slides mounted in entellan.
Active caspase-8 immunostaining was performed similarly
with NovoLink Polymer Detection System (Novocastra Lab-
oratories, Newcastle, UK) and a caspase-8 primary antibody
(Mouse Monoclonal Antibody Caspase-8, Novocastra; 1:1000
diluted in PBS).
For all immunoreactions a negative control slide was
used, with the same treatment described above only omitting
primary antibody labelling.
Stereological analysis
Testicular tissue preparation for analysis is usually carried out
by paraffin inclusion or other embedding media followed by
3–4 μm sections cuts. This procedure can induce cell
distortion in number, size and shape within the section
analyzed. In order to overcome possible bias, stereological
tools were introduced in histological analysis of testicular
tissue [26]. Stereological analysis ensures an uniformed
sample where Sertoli cells and germ cells from all stages
have the same probability to be sampled and where pos-
sible distortions in cell volume and orientation during
histological processing will not interfere with the final
results [19, 26]. In addition, despite several seminiferous
tubules are analyzed, a testicular section only provides
estimation on how the entire testis might function. This
method provides information relative to the total number
of cells in testis in order that final results truly represent
the entire testis [19].
Only one testicular section per patient was analysed and,
when possible, about 20 seminiferous tubules were evaluated.
Samples were analysed under light microscopy (LEITZ
DMR—Leica, Germany), with digital camera (DFC480—
R2, Leica) and appropriate analysis software (Leica Image
Manager 50—IM50, Switzerland). The presence of active
caspases-3, −8 and −9 was estimated per germ cells (sper-
matogonia—SG, primary—ST1, and secondary—ST2 sper-
matocytes, round spermatids—Sa) and Sertoli cells (SC),
either per seminiferous tubules or per testicular volume
using stereological tools.
The parameter VV represents the relative volume oc-
cupied by a cell relatively to a specific reference space.
Considering seminiferous tubules as the reference space,
each VV is determined by a manual point counting [23],
using a multi-system grill placed over the image obtained
using an immersion oil objective (100x) (Fig. 1). After
counting, results were calculated with the following
computation:
VV (cell, seminiferous tubules)=[∑P(cell) x 100] ÷ [R ∑P
(seminiferous tubules)], where “∑P(cell)” corresponds to the
total number of points counted over the cell of interest, “∑P
(seminiferous tubules)” corresponds to the total number of
points over the seminiferous tubules from the testicular
section in study, and “R” to the ratio of points considering
the counting system used for the analysed cells and for the
reference space (seminiferous tubules). This computation
gives the estimation of the volume occupied per cell in
seminiferous tubules and was calculated per patient in all
pathologies. In the seminiferous tubule, results are expressed
as relative volume (Vv) occupied per cell with or without
active caspases.
In order to calculate the volume per cell occupied in the
testis, the following computations were used:
VV (cell, biopsy)=VV (cell, seminiferous tubules) x
VV (seminiferous tubules, biopsy) and V (cell, testis)=VV
(cell, biopsy) x V (biopsy, testis), where the total volume of
each biopsy was estimated by fluid displacement before
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preparation of samples for paraffin impregnation. The VV
(seminiferous tubules, biopsy) is estimated by point count-
ing with a multi-system grill (Integrationsplatte II, 100/25,
Carl Zeiss) directly in the microscope ocular and with a
10x objective (Fig. 1). In the entire testis, results are
expressed as volume (V) occupied per cell with or without
active caspase labelling.
Statistical analysis
Different approaches were applied in the analysis of the
relative (Vv) and total (V) volume occupied per cell with
active caspases-8, −9 and −3 in both seminiferous tubules
and testis, respectively. For each caspase, comparisons were
made per group of patients (Oligozoospermia, CBAVD,
secondary obstruction, hypospermatogenesis, maturation ar-
rest and SCOS) among germ cell types (SC, SG, ST1, ST2,
Sa) and also per germ cell type among groups of patients.
Kruskal-Wallis test with a 95 % confidence interval (CI) was
applied. Multiple comparisons were also performed between
cells by the Mann–Whitney U Test (95 % CI) and per group
of patients. Ten different comparisons were made: SCvsSG,
SCvsST1, SCvsST2, SCvsSa, SGvsST1, SGvsST2,
SGvsSa, ST1vsST2, ST1vsSa, ST2vsSa. The Bonferroni
method was used to adjust the significance level owing to
multiple Mann–Whitney tests. The significance level of
0.05 was maintained using the formula of 0.05O/k inde-
pendent hypotheses, with k=10 to reflect the ten planned
analyses of interest detailed above. An adjusted signifi-
cance level of 0.005 was therefore used to maintain the
overall 0.05 level in the context of the multiple compar-
isons. Finally, comparisons between active caspase-8 and
active caspase-9 relative (Vv) and total volume (V), per
group and per cell, were performed using the Mann–
Whitney U Test (95 % CI).
In all approaches, medians were used instead of means as
no normal distribution was shown by active caspases-8, −9
and −3 Vv and V values, in all groups. All comparisons
were performed using Stata (version 9).
Results
In all groups, active caspases-8, −9 and −3 immunostaining
were observed in Sertoli cells’ cytoplasm and germ cells’
cytoplasm and nucleus (Fig. 2).
The relative and total volume medians of Sertoli cells and
germ cells with active caspases-8, −9 and −3 per testicular
groups are shown in Fig. 3.
Seminiferous tubules
Active caspase-8
In all groups, increased Vv(SC) with active caspase-
8 (casp8+) was shown to be present in relation to all
germ cells types, with no significant differences being
found among groups (P=0.632). Comparisons per group
revealed significant differences among germ cell types in
cases of Oligozoospermia and secondary obstruction
(Table 1). Although no significant differences were found
by multiple comparisons between germ cell types, in-
creased Vv(ST1)casp8+ was observed in both groups. No
significant differences were observed in comparison to
oligozoospermia and among the other groups, per germ cell
type (Table 1).
Active caspase-9
Increased Vv(SC) with active caspase-9 (casp9+) was ob-
served in all groups in relation to germ cells, but with no
significant differences among groups (P=0.554). Comparisons
per group showed significant differences among germ cell
types (P=0.033, Table 1). Again, increased Vv(ST1)casp9+
A
B
Fig. 1 Grill systems used for the stereological analysis performed. a
Howard and Reed multi-scale system placed over a seminiferous tubule
image on the computer (100×) in order to estimate the relative volume
(Vv) occupied per cell per seminiferous tubule; b Grill inserted in the left
microscope ocular (10×) in order to estimate the volume (V) occupied per
cell in the testis (Integrationsplatte II, 100/25, Carl Zeiss)
490 J Assist Reprod Genet (2013) 30:487–495
was found in all groups (Table 1). Contrarily to casp8+, com-
parisons per germ cell stage among groups, including oligo-
zoospermia, showed significant differences (P=0.011) with
increased Vv(SG)casp9+ and Vv(ST1)casp9+ in secondary
obstruction and increased Vv(ST2)casp9+ and Vv(Sa)casp9+
in CBAVD (Table 1).
Active caspase-3
Increased Vv(SC) with active caspase-3 (casp3+) was pres-
ent in all groups in relation to germ cells and significant
differences were found among groups (P=0.009). Increased
values were shown by SCOS and hypospermatogenic
CASPASE-8 CASPASE-9 CASPASE-3
O
Z
C
BA
V
D
sO
A
Z
H
P
M
A
SC
O
S
ST1
SC
SG
ST2
SG
Sa
Fig. 2 Active caspases-8, −9
and −3 immunohistochemical
analysis for the testicular
groups analyzed. OZ—
Oligozoospermia; CBAVD—
congenital bilateral absence of
the vas deferens; sOAZ—
secondary obstructive
azoospermia; HP—
hypospermatogenesis; MA—
maturation arrest; SCOS—
Sertoli-cell-only syndrome.
SC—Sertoli-cell; SG—
spermatogonia; ST1—primary
spermatocyte; ST2—secondary
spermatocte; Sa—round
spermatid; Bar=50 μm
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Seminiferous Tubules
Testis
Active Caspase-9 Active Caspase-3Active Caspase-8
OZ CBAVD  sOAZ HP MA SCOS OZ CBAVD  sOAZ HP MA SCOS
OZ CBAVD  sOAZ HP MA SCOS OZ CBAVD sOAZ HP MA SCOS
OZ CBAVD  sOAZ HP MA SCOS
OZ CBAVD  sOAZ HP MA SCOS
Fig. 3 Median values for relative volume (Vv) and volume (V) occu-
pied by Sertoli cells and germ cells with active caspases-8, −9 and −3,
in the seminiferous tubules and testis, respectively. OZ—Oligozoo-
spermia; CBAVD—congenital bilateral absence of the vas deferens;
sOAZ—secondary obstructive azoospermia; HP—hypospermatogenesis;
MA—maturation arrest; SCOS—Sertoli-cell-only syndrome
Table 1 Relative volumes of
active caspases-8, −9 and −3 per
germ cell stage per seminiferous
tubules
SC sertoli cell, SG spermatogo-
nia, ST1 primary spermatocyte,
ST2 secondary spermatocyte, Sa
round Spermatid, OZ oligozoo-
spermia, CBAVD congenital
bilateral absence of the vas
deferens, sOAZ secondary
obstructive azoospermia, HP
hypospermatogenesis, MA
maturation arrest, Vv relative
volume (expressed in median)
aComparisons per group among
cell stages (except SC);
bcomparisons per cell stage
among groups
vV SC vV SG vV ST1 vV ST2 vV Sa Pa
Active caspase-8
OZ 0,0169 0,0009 0,0037 0,0001 0,0005 0,0047
CBAVD 0,0187 0,00135 0,00785 0,00115 0,00125 0,1021
sOAZ 0,0156 0,0005 0,0039 0,0002 0,0004 0,0067
HP 0,0146 0,0003 0,0018 0,00018 0,00019 0,1254
MA 0,0267 0,0007 0,0013 0,0002 – 0,0509
Pb 0,632 0,424 0,282 0,071 0,055
Active caspase-9
OZ 0,0105 0,0015 0,0019 0,0001 0,00003 0,0019
CBAVD 0,0110 0,0015 0,0085 0,0006 0,0002 0,0037
sOAZ 0,0187 0,0019 0,0102 0,0006 0,0002 0,0043
HP 0,0076 0,0008 0,0035 0,0002 0,00003 0,0010
MA 0,0092 0,0008 0,0051 0 – 0,0330
Pb 0,554 0,009 0,003 0,011 0,004
Active caspase-3
OZ 0,0037 0,0004 0,0034 0,0005 0,0001 0,0018
CBAVD 0,0085 0,0005 0,0061 0,0009 0,0001 0,0162
sOAZ 0,0128 0,0026 0,0098 0,0011 0,0001 0,0010
HP 0,0162 0,0014 0,0060 0,0004 0 0,0061
MA 0,0097 0,0015 0,0046 0 – 0,0568
Pb 0,009 0,014 0,010 0,018 0,019
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patients (Table 1). Among germ cell types, all groups,
except MA (P=0.057) presented significant differences
(Table 1). Although no significant differences were ob-
served by multiple comparisons between germ cell
types, increased Vv(ST1)casp3+ was found in all testic-
ular syndromes. Significant differences were observed
when comparisons were made per germ cell stage and
among groups (P=0.019). Increased Vv(SG)casp3+, Vv
(ST1)casp3+, Vv(ST2)casp3+ and Vv(Sa)casp3+ were
all observed for secondary obstruction in relation to the
other groups. It should be noted that oligozoospermic men
showed the lowest levels of casp3+ in SC and in all germ
cells except for Sa where no casp3+ cell was analyzed for
hypospermatogenic patients.
Active caspase-8 vs active caspase-9
Comparisons per group showed significant increased Vv
(Sa)casp8+ (P=0.009) and significant increased Vv
(SG)casp9+ (P=0.009) in oligozoospermia. Hyposper-
matogenic patients showed significant increased Vv
(Sa)casp9+ (P=0.028). No significant differences were
observed between casp8+ and casp9+ for the other
groups (P=0.076).
Testis
Active caspase-8
Results obtained were similar to those obtained at the
seminiferous tubule level. Increased V(SC)casp8+ was
present in all groups but with no significant differences
among them (P=0.706). Significant differences among
germ cell types were observed in cases of oligozoo-
spermia and secondary obstruction that presented in-
creased but not significant V(ST1)casp8+. No significant
differences were observed per germ cell stage among
groups.
Active caspase-9
Increased V(SC)casp9+ was observed in all groups in rela-
tion to germ cell type, but with no significant differences
among groups (P=0.102). Comparisons per group showed
significant differences for the presence of casp9+ among
germ cells (P=0.007) with increased but not significant V
(ST1)casp9+ in all groups. An exception was observed
within maturation arrest where no significant differences
were found (P=0.058). Contrarily to seminiferous tubules,
comparisons per germ cell stage among groups showed
significant differences only for V(Sa)casp9+ (P=0.048)
with increased but not significant V(Sa)casp9+ in secondary
obstruction.
Active caspase-3
Increased V(SC)casp3+ was present in all groups in relation
to germ cell type and significant differences were found
among groups (P=0.009) with increased values shown by
SCOS and hypospermatogenic patients. Among germ cell
type, all groups, except MA (P=0.058) presented significant
differences (P=0.021). Even though multiple comparisons
revealed no significant differences between germ cell types,
increased V(ST1)casp3+ was found in all testicular syn-
dromes. Comparisons per germ cell among groups showed
only significant differences for V(Sa)casp3+ (P=0.029)
with increased values in CBAVD.
Active caspase-8 vs active caspase-9
Oligozoospermia showed significant increased V(SG)casp9+
(P=0.016) and V(Sa)casp8+ (P=0.009). Hypospermatogene-
sis showed significant increased V(Sa)casp8+ (P=0.047).
Discussion
In men with normal sperm output a fine balance between
germ cell proliferation and germ cell apoptosis exists [13].
Sertoli cells are responsible for germ cell nurture and sup-
port, controlling the number of germ cell production [12]. In
the presence of excessive or damaged germ cells, Sertoli
cells express FasL inducing germ cell apoptosis by the
Fas/FasL system in order to maintain equilibrium, essential
to normal spermatogenesis [25]. However, sometimes the
adverse conditions are not overcome and this equilibrium is
not reached. Increased rates of apoptosis have already been
described in cases of azoospermia [17, 18]. However, the
apoptotic mechanisms involved are still poorly understood.
Increased rates of DNA fragmentation and active caspase-3
were found in testes from patients with SCOS and maturation
arrest [16] and decreased rates of TUNEL-positive germ cells
were found in hypospermatogenesis, CBAVD and secondary
obstruction cases [4]. However, different studies present dis-
cordant results [28].
To characterize apoptosis during impaired spermatogen-
esis the rates of apoptosis in testicular tissue from fertile
men should be assessed. Due to the difficulty in obtaining
testicular samples from normozoospermic individuals, we
used oligozoospermic patients which although presenting a
decreased number of ejaculated sperm have conserved tes-
ticular histology with no obstruction [21].
In the present study, the quantification of apoptosis was
performed in Sertoli cells and germ cells using stereological
analysis. The presence of active caspases −3, −8 and −9 was
determined first at the seminiferous tubule level and then
results were calculated for the entire testis.
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In all cases, Sertoli cells presented higher apoptosis in
comparison to germ cells. No significant differences were
observed among groups for the presence of active caspase-
8 and active caspase-9. During normal spermatogenesis,
Sertoli cells and germ cells die by apoptosis in order to
maintain equilibrium [15]. In the present study increased
levels of Sertoli cells with active caspase-3 were found in
SCOS patients suggesting that apoptosis might be an active
mechanism in this syndrome. Results are in concordance
with previous data where increased TUNEL-positive Sertoli
cells and increased rates of active caspase-3 were found in
SCOS patients [16].
Contrarily to previous studies where the FasR/FasL
system with caspase-3 activation was suggested to be
involved in germ cell degeneration in cases of maturation
arrest [7, 8, 16], our results suggest no active role for
apoptosis in this syndrome. On the contrary, another study
showed increased immunostaining of active caspase-3 in
spermatocytes or spermatocytes and spermatids in cases of
incomplete [4] and complete maturation arrest [14]. These
discordant results might be due to differences in MA
histology as well as to differences in germ cell quantification
and analysis.
In cases of conserved spermatogenesis (secondary ob-
struction, CBAVD and hypospermatogenesis), although no
significant results were observed, primary spermatocytes
showed higher active caspase-3 in comparison to all other
germ cell types. Results suggest that a malfunction might
exist in the meiotic phase of spermatogenesis, namely in the
first meiotic phase, and that might be on the origin of these
testicular pathologies. In secondary obstruction significant
differences were observed for active caspase-8 and active
caspase-9 among germ cells but no differences were found
between both. Although the intrinsic and the extrinsic apo-
ptotic pathways seemed to be present, results suggest that
none of them are likely to prevail. Extrinsic factors on the
origin of the obstruction might activate the extrinsic apoptotic
pathway with caspase-8 activation but a cross-talk between
the intrinsic and the extrinsic pathways, with mitochondrial
apoptotic factors release, apparently co-exist, with both mech-
anisms contributing to the apoptotic germ cell death observed
in secondary obstruction. In cases of CBAVD, no significant
differences were found among germ cells for the presence of
active caspase-8. On the contrary, significant differences for
the presence of germ cells with active caspase-9 and active
caspase-3 were observed, with higher levels of labeling
appearing at the primary spermatocyte stage, thus suggesting
activation of the intrinsic apoptotic pathway. In this mecha-
nism, endoplasmic reticulum and mitochondrial lesions might
be involved [23].
Previous studies on testicular spermatozoa have shown
increased rates of active caspase-3 in secondary obstruction
and CBAVD patients, with staining observed mainly in the
sperm nucleus [2]. In the present study, active caspase-3
immunostaining was observed in germ cells cytoplasm
and/or nucleus suggesting that external and internal lesions
in cases of secondary obstruction and only internal lesions
in CBAVD patients might activate the apoptotic pathway
inducing caspase-3 activation among germ cells and conse-
quent translocation to the nucleus during spermiogenesis.
Like in CBAVD, no significant differences were found
for the presence of active caspase-8 among germ cells in
hypospermatogenic patients. In these patients significant
differences were found for the presence of active caspase-9
with higher levels at the primary spermatocyte stage, sug-
gesting that apoptosis through the intrinsic mechanism
might be on the origin of the lower numbers of germ cells
observed in hypospermatogenic patients. Additionally, in
HP, the number of Sertoli cells with active caspase-3 was
the highest among all syndromes (exluding SCOS). These
results reinforce the results obtained recently where in-
creased rates of active caspase-3 were shown to be present
in the midpiece of testicular spermatozoa from hyposperma-
togenic patients [2].
It should be noted that oligozoospermic men showed
the lowest levels of caspase-3 in SC and in all germ cells
except for Sa where no caspase-3 positive cell was ana-
lysed for hypospermatogenic patients. Significant differ-
ences for the presence of active caspase-8 and active
caspase-9 were observed among germ cells, with in-
creased levels at the primary spermatocyte stage. Compar-
isons between both proteins showed significant increased
spermatogonia with active caspase-9. Previous results
have suggested the presence of a post-testicular apoptotic
induction factor as the main cause of decreased ejaculated
spermatozoa [2, 3]. The present additional findings sug-
gest that germ cell death induced by internal apoptotic
factors and meiosis malfunctioning during spermatogene-
sis might also be on the origin of decreased sperm production
observed in these men.
In conclusion, no significance for apoptosis was found
for maturation arrest whereas in SCOS increased levels
of active caspase-3 were shown to be present. In all
other pathologies (oligozoospermia, secondary obstruction
and CBAVD), meiotic germ cell apoptosis seemed to be
present. Apoptosis in cases of secondary obstruction is
suggested to be initiated by extrinsic factors and intrinsic
lesions, whereas in CBAVD only the intrinsic apoptotic
pathway seemed to be present. The low numbers of germ
cells observed in hypospermatogenesis are suggested to
result from Sertoli cell death by apoptosis and mitochon-
drial lesions at the primary spermatocyte stage. Finally,
in oligozoospermic patients, spermatogonia death by mi-
tochondrial damage and meiosis malfunctioning during
spermatogenesis might be on the origin of the decreased
sperm output.
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